tetano
Editor, Senior Moderator
Virology
. 2021 Apr 21;559:165-172.
doi: 10.1016/j.virol.2021.04.006. Online ahead of print.
Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses
Evelyn A Kurt-Jones[SUP] 1 [/SUP], Timothy E Dudek[SUP] 2 [/SUP], Daisuke Watanabe[SUP] 2 [/SUP], Leisa Mandell[SUP] 1 [/SUP], Jenny Che[SUP] 1 [/SUP], Shenghua Zhou[SUP] 1 [/SUP], LuCheng Cao[SUP] 1 [/SUP], Thomas Greenough[SUP] 1 [/SUP], Gregory J Babcock[SUP] 3 [/SUP], Fernando Diaz[SUP] 2 [/SUP], Hyung Suk Oh[SUP] 2 [/SUP], Changhong Zhou[SUP] 2 [/SUP], Robert W Finberg[SUP] 1 [/SUP], David M Knipe[SUP] 4 [/SUP]
Affiliations
Abstract
SARS coronavirus 1 (SARS-CoV-1) causes a respiratory infection that can lead to acute respiratory distress characterized by inflammation and high levels of cytokines in the lung tissue. In this study we constructed a herpes simplex virus 1 replication-defective mutant vector expressing SARS-CoV-1 spike protein as a potential vaccine vector and to probe the effects of spike protein on host cells. The spike protein expressed from this vector is functional in that it localizes to the surface of infected cells and induces fusion of ACE2-expressing cells. In immunized mice, the recombinant vector induced antibodies that bind to spike protein in an ELISA assay and that show neutralizing activity. The spike protein expressed from this vector can induce the expression of cytokines in an ACE2-independent, MyD88-dependent process. These results argue that the SARS-CoV-1 spike protein intrinsically activates signaling pathways that induce cytokines and contribute directly to the inflammatory process of SARS.
Keywords: Cytokines; Herpes simplex virus; SARS coronavirus.
. 2021 Apr 21;559:165-172.
doi: 10.1016/j.virol.2021.04.006. Online ahead of print.
Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses
Evelyn A Kurt-Jones[SUP] 1 [/SUP], Timothy E Dudek[SUP] 2 [/SUP], Daisuke Watanabe[SUP] 2 [/SUP], Leisa Mandell[SUP] 1 [/SUP], Jenny Che[SUP] 1 [/SUP], Shenghua Zhou[SUP] 1 [/SUP], LuCheng Cao[SUP] 1 [/SUP], Thomas Greenough[SUP] 1 [/SUP], Gregory J Babcock[SUP] 3 [/SUP], Fernando Diaz[SUP] 2 [/SUP], Hyung Suk Oh[SUP] 2 [/SUP], Changhong Zhou[SUP] 2 [/SUP], Robert W Finberg[SUP] 1 [/SUP], David M Knipe[SUP] 4 [/SUP]
Affiliations
- PMID: 33930819
- PMCID: PMC8058630
- DOI: 10.1016/j.virol.2021.04.006
Abstract
SARS coronavirus 1 (SARS-CoV-1) causes a respiratory infection that can lead to acute respiratory distress characterized by inflammation and high levels of cytokines in the lung tissue. In this study we constructed a herpes simplex virus 1 replication-defective mutant vector expressing SARS-CoV-1 spike protein as a potential vaccine vector and to probe the effects of spike protein on host cells. The spike protein expressed from this vector is functional in that it localizes to the surface of infected cells and induces fusion of ACE2-expressing cells. In immunized mice, the recombinant vector induced antibodies that bind to spike protein in an ELISA assay and that show neutralizing activity. The spike protein expressed from this vector can induce the expression of cytokines in an ACE2-independent, MyD88-dependent process. These results argue that the SARS-CoV-1 spike protein intrinsically activates signaling pathways that induce cytokines and contribute directly to the inflammatory process of SARS.
Keywords: Cytokines; Herpes simplex virus; SARS coronavirus.